Marta De Donato
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Genomic profiling as an option for ovarian cancer diagnostics.
Journal: Expert review of molecular diagnostics
Published: July 09, 2026
Deciphering brain metastasis in epithelial ovarian cancer: multimodal analysis and potential biomarkers.
Journal: NPJ precision oncology
Published: April 29, 2025
Design and synthesis of pyridopyrimidines targeting NEK6 kinase.
Journal: Archives of biochemistry and biophysics
Published: December 11, 2024
KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer.
Journal: Journal of experimental & clinical cancer research : CR
Published: September 17, 2020
Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer.
Journal: Cancers
Published: March 17, 2020
Identification and antitumor activity of a novel inhibitor of the NIMA-related kinase NEK6.
Journal: Scientific reports
Published: May 30, 2018
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer.
Journal: Gynecologic oncology
Published: March 22, 2017
GTP is an allosteric modulator of the interaction between the guanylate-binding protein 1 and the prosurvival kinase PIM1.
Journal: European journal of medicinal chemistry
Published: June 12, 2014
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness.
Journal: Gene
Published: December 12, 2013
Gli family transcription factors are drivers of patupilone resistance in ovarian cancer.
Journal: Biochemical pharmacology
Published: July 05, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026